We have located links that may give you full text access.
Can peanut agglutinin distinguish between pseudo and true invasion in colonic adenomas?
We verified the binding of peanut agglutinin (PNA) in 28 pedunculated adenomas (10 with pseudo and 18 with true invasion, respectively) of the large bowel. The distribution of glycoproteins was assessed in the normal mucosa of the stalk, in the surface dysplastic mucosa and in the mucosa of the pseudo-invasion or cancerization areas. The aims of the study were to verify: the PNA role in the differential diagnosis between pseudo and true invasion; the changes in PNA binding during transformation of mucosa from the normal to dysplastic and neoplastic status; the PNA ability as a predictive marker in the neoplastic transformation. The total percentage of PNA positivity in our samples was not significatively higher in carcinomatous than in pseudoinvasive areas (83.3% vs 50%). But the analysis of semiquantitative expression of PNA binding showed that an analogous, or reduced expression of marker in the epithelium in the submucosa compared to the dysplastic surface was consistent with the diagnosis of pseudoinvasion, while its increase strengthened the diagnosis of true invasion. In addition, we found a progressive increase of expression of PNA from the normal to dysplastic and neoplastic mucosa; therefore our data confirmed the quantitative relationship of this marker with malignant transformation. Finally, when we compared the expression of the PNA binding in solely superficial adenomatous tissue of benign and malignant polyps, we found an equal percentage of positive cases (66.6% in the carcinomatous vs 70% in the benign adenomas). Therefore, PNA does not recognize the risk of actual malignant evolution in an adenoma but is indicative of carcinomatous transformation when it is strongly positive.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app